Abstract:<p>Bladder cancer is a menace to global health worldwide due to its high recurrence rate and its progression to invasive muscular complications. Cell adhesion molecules play an intricate role in cancer migration, growth, and invasion. Therefore, through bioinformatics analysis, it was found that the higher cerebral endothelial cell adhesion molecule (CERCAM) predicted lower chance in bladder cancer patient survival; subsequently, in vitro and in vivo investigations were performed to evaluate the specific effects of CERCAM on bladder cancer cell phenotypes and tumor growth in mice model. The PCR-based analysis revealed an aberrant upregulation of CERCAM in bladder carcinoma tissues and cells when compared with normal controls. In vitro, functional experiments such as MTT, EdU, and Transwell assays showed that CERCAM overexpression markedly enhanced bladder cancer cell viability, DNA synthesis, and cell invasion. In contrast, CERCAM silencing suppressed bladder cancer cell viability, DNA synthesis, and cell invasion. CERCAM overexpression significantly increased PCNA, Vimentin, Twist, and N-cadherin proteins but decreased E-cadherin and cleaved-caspase3, whereas CERCAM silencing exerted opposite effects on these markers. In vivo, subcutaneous implant model experiments in nude mice showed that CERCAM silencing suppressed the growth of subcutaneously implanted tumors. CERCAM altered the phosphorylation process of AKT. The PI3K inhibitor LY294002 treatment manifested similar effects as CERCAM silencing on bladder cancer cell behaviors and partially impaired the promotive functions of CERCAM overexpression upon the capacity of bladder cancer cells to proliferate and invade. When taken together, the cell adhesion molecule CERCAM is overexpressed in bladder cancer tissues. In vitro, CERCAM overexpression significantly promoted bladder cancer cell viability, DNA synthesis, and cell invasion and alters the cleaved-caspase3, E-cadherin, and N-cadherin expression pattern; in vivo, CERCAM silencing suppressed tumor growth in nude mice. The PI3K/AKT signaling is suspected of interfering participate in the functions of CERCAM in bladder carcinoma.</p>

CRYAB Inhibits Migration and Invasion of Bladder Cancer Cells Through the PI3K/AKT and ERK Pathways.

The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo

[Research on the anti-tumor effects of CRYAB in prostate cancer]

EDARADD Silencing Suppresses the Proliferation and Migration of Bladder Cancer Cells

Α-E-catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer.

Αb-Crystallin is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells.

Γ-Secretase Inhibitor Inhibits Bladder Cancer Cell Drug Resistance and Invasion by Reducing Epithelial-Mesenchymal Transition

Down-regulation of astrocyte elevated gene-1 expression inhibits the proliferation and invasion of human bladder cancer T24 cells

Cxcl5/Cxcr2 Axis Promotes Bladder Cancer Cell Migration And Invasion By Activating Pi3k/Akt-Induced Upregulation Of Mmp2/Mmp9

Alpha-B-Crystallin: A Novel Protein Associated with Invasive Glioma Phenotype

CCL18 Enhances Migration, Invasion and EMT by Binding CCR8 in Bladder Cancer Cells

Downregulation of Angiogenin Inhibits the Growth and Induces Apoptosis in Human Bladder Cancer Cells Through Regulating AKT/mTOR Signaling Pathway.

P85 Alpha Inactivates Mmp-2 And Suppresses Bladder Cancer Invasion By Inhibiting Mmp-14 Transcription And Timp-2 Degradation

The role and clinical significance of αB-Crystallin in the proliferation and migration of non-small cell lung cancer

PI3K/Akt to GSK3β/β-catenin Signaling Cascade Coordinates Cell Colonization for Bladder Cancer Bone Metastasis Through Regulating ZEB1 Transcription.

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma

KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-κB signaling

The Role of CRYAB in Tumor Prognosis and Immune Infiltration: A Pan-cancer Analysis

Downregulation of HDGF Inhibits the Tumorigenesis of Bladder Cancer Cells by Inactivating the PI3K-AKT Signaling Pathway.

Cancer-associated Fibroblasts Promote Cisplatin Resistance in Bladder Cancer Cells by Increasing IGF-1/ERβ/Bcl-2 Signalling

CAB39 modulates epithelial-mesenchymal transition through NF-κB signaling activation, enhancing invasion, and metastasis in bladder cancer